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These modiﬁcations are often dynamic, and their removal is just as important as their addition in
proper regulation of cellular functions. Although histone acetylation/deacetylation and histone
methylation/demethylation are highly studied, the functions and regulation of histone ubiquitina-
tion and deubiquitination are less well understood. This review highlights our current understand-
ing of how histone ubiquitination impacts gene transcription, DNA repair, and cell cycle
progression, and stresses the importance of deubiquitinases to normal cellular functions as well
as to disease states such as cancer.
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on of the manuscript.1. Introduction
The conjugation of ubiquitin (Ub) molecules to intracellular
proteins has emerged as a critical regulatory process in virtually
all aspects of cell biology. Ub is attached to target proteins as a
means of regulating the half-life, localization and activity of many
polypeptides. Through a cascade including a Ub activating enzyme
(E1), dozens of Ub conjugating enzymes (E2s), and hundreds of Ub
ligases (E3s), Ub is speciﬁcally attached to targeted proteins in a
precisely timed and accurate manner. Ub addition may take the
form of single molecule attachment to one or multiple lysines
(mono-ubiquitination) or may occur as Ub chains (poly-ubiquitina-
tion) with each subsequent Ub attached to a lysine of the prior.
These Ub chains may exist in several formats depending on the
lysine that is used for these inter-Ub linkages. Several lysines are
utilized for chain formation including Lysine 6, (K6), K11, K29,
K48 and K63. Proteasome targeting is accomplished primarily
through the formation of K48-linked chains. K63 linkages perform
more diverse functions by altering target protein structure, locali-
zation or activity.
Deubiquitination is the removal of Ub molecules from targeted
substrates and is mediated by a group of enzymes that belong to
the superfamily of proteases, known as deubiquitinating enzymes
(DUBs). These DUBs have been grouped into ﬁve subfamilies: (1)
the ubiquitin carboxy-terminal hydrolases (UCHs), (2) the
ubiquitin-speciﬁc proteases (USPs)/ubiquitin-speciﬁc processing
proteases, (3) the ovarian tumor proteases, (4) the Josephin orlsevier B.V. All rights reserved.
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Jab1/MPN domain-associated metalloisopeptidase domain pro-
teins. The ﬁrst four subfamilies are cysteine peptidases, while the
last one is zinc metalloisopeptidase [1]. The mechanistic details
of deubiquitination are still much less understood than the mech-
anism of the ubiquitination pathway. An important role of the
DUBs is emerging from (a) the identiﬁcation of a growing number
of substrates and (b) from the structural analyses that show how
conformational changes regulate substrate speciﬁcity and tightly
control enzymatic activity [2].
Several DUBs have been identiﬁed to target histones and this
interaction has great impact on chromatin structure and down-
stream DNA-based processes. The ubiquitination of histones has
been described for several decades, as H2A was the ﬁrst protein
shown to be ubiquitinated in cells [3], and the number of enzymes
and their interacting partners that regulate the addition or removal
of Ub from histones increased rapidly. Histone ubiquitination has
been primarily linked to transcriptional activation or repression,
depending on the chromatin context, but the addition of Ub to
chromatin components affects many more DNA-based processes,
like cell cycle progression, DNA damage repair, X chromosome
inactivation and gene silencing. In this review we will discuss re-
cent advances on DUBs that have been identiﬁed to play a role in
the regulation of histone deubiquitination, their role in establish-
ing a ﬁne balance of chromatin ubiquitination–deubiquitination,
and how the deregulation of this balance may contribute to cancer
development.2. Histone ubiquitination and deubiquitination in
transcriptional regulation
H2B ubiquitination was the ﬁrst histone modiﬁcation found to
be required for addition of a second modiﬁcation on a different
histone, indicative of regulatory ‘‘crosstalk” between histone
modiﬁcations. H2B ubiquitination is a prerequisite for H3K4 and
-K79 tri-methylation, but not for H3K36 methylation [4]. Intrigu-
ingly, the absence of H3K4 methylation, in yeast cells expressing
a H3K4R mutant, does not affect H2B ubiquitination, demonstrat-
ing that this regulatory pathway is unidirectional [4]. The path-
way connecting H2B ubiquitination to H3K4 methylation is best
deﬁned in yeast, and it consists of a highly orchestrated set of
events. The methyltransferase Su(var)3-9/Enhancer of zeste/tri-
thorax domain protein 1 (Set1) is recruited as part of the complex
proteins associated with Set1 (COMPASS) complex to the tran-
scription machinery through another complex, the polymerase
II-associated factor (Paf) complex, and the resulting H3K4 methyl-
ation has been suggested to provide a memory of recent tran-
scription [5]. The yeast Paf complex is also required for H2B
ubiquitination [6,7] and deletion of either the Rtf1 subunit or
the Paf1 subunit results in drastic loss of H2B ubiquitination. Fur-
thermore, Rtf1 enables the Bre1–Rad6 E2/E3 complex to associate
with RNA Polymerase II (RNA PolII) during transcription elonga-
tion. However, unlike Bre1, neither Rtf1 nor Paf1 are required
for the recruitment of the Rad6 E2 enzyme to the promoter of ac-
tive genes [8]. The ubiquitination of H2B occurs only after the
Rad6–Bre1 complex associates with the elongating form of PolII
that is phosphorylated at Ser 5 of the carboxy-terminal domain
(CTD) (Fig. 1A). Human homologs of Bre1, Ring ﬁnger protein
20 (RNF20) and RNF40, associate with a human RAD6 homolog,
to form an E2–E3 complex that is required for H2B monoubiqui-
tination both in vivo and in vitro [9]. Kim and colleagues found
that the knockdown of RNF20 in HEK 293T cells recapitulated
the cross talk between histone ubiquitination and tri-methylation
that has been observed in yeast [10], however Shema et al. did
not observe signiﬁcant changes in the global levels of H3K4me3in HeLa cells depleted for RNF20 [11], bringing the conservation
of the trans-histone pathway between species or cell types into
question.
Although the regulation of Set1-mediated H3K4 methylation
and disruptor of telomeric silencing 1 (Dot1)-mediated H3K79
methylation by H2BK123 ubiquitination has been extensively
studied, there are still questions about how uH2B impacts chroma-
tin structure and Set1/Dot1 functions. One possibility is that ubiq-
uitin binds proteins and physically acts as a bridge between uH2B
and Set1/Dot1. Another possibility is that ubiquitin acts as a
‘‘wedge” that facilitates access by dissociation of the nucleosome.
However, more recent discoveries favor a role for the ubiquitin
molecule in stabilizing the nucleosome as it prevents the eviction
of H2A–H2B [12]. Cps35/Swd2, a component of yeast COMPASS,
which contains Set1, appears to mediate crosstalk between ubiqui-
tinated H2B and H3K4 methylation [13]. Proteasome components
are also recruited to active genes via H2B ubiquitination, possibly
to reconﬁgure chromatin for access of Set1 and Dot1 during tran-
scription [14]. However, H2BK123 ubiquitination does not appear
to regulate recruitment of the methyltransferase complexes but in-
stead controls their processivity [15].
H2B deubiquitination mediated by Ubp8, the yeast ortholog of
USP22 within the Spt-Ada-Gcn5 acetyltransferase complex (SAGA)
has a role in transcriptional activation of GAL genes and positively
regulates the levels of H3K4 trimethylation, highlighting the role
of the DUBs in transcriptional regulation [16]. On the contrary
Henry et al. found that both H2B monoubiquitination and deubiq-
uitination are involved in gene activation, as Rad6 and Ubp8 have
opposing functional roles in histone ubiquitination during
transcriptional activation of the GAL genes [17]. A more complex
regulation of H3K4 methylation has been described in vivo when
different SAGA-regulated genes were studied in a Ubp8 mutant
background [18], complicating even further our understanding of
the function of histone ubiquitination as an activating or a repres-
sive mark. In mammalian cells, ubiquitinated H2B was found to
associate with the transcribed region of highly expressed genes
[19], suggesting a positive role in transcription regulation, but the
knockdown of RNF20, an E3 ubiquitin ligase responsible for H2B
ubiquitination, affected the basal expression of only a subset of
genes [11]. H2B ubiquitination appears to be required for initial
stages of transcription in yeast, but creates a barrier for transcrip-
tional elongation of SAGA-regulated genes by blocking carboxy-ter-
minal domain kinase 1 recruitment to the PolII CTD, and this barrier
needs to be removed for successful transcription to proceed [20].
However, in vitro transcription elongation assays using a highly
reconstituted chromatin system established a role for H2B mono-
ubiquitination in facilitating facilitates chromatin transcription
(FACT) function, thereby stimulating transcript elongation and the
generation of longer transcripts [21].
H2A is the preferred ubiquitination histone substrate in mam-
malian cells. Ubiquitinated H2A has been estimated to comprise
between 5% and 15% of total H2A, compared to about 1% of overall
H2B ubiquitination. Monoubiquitination of H2A by Ring1B E3
ubiquitin ligase, which is a subunit of the transcriptional repressor
Polycomb repressive complex 1 (PRC1) Polycomb-group complex,
linked histone ubiquitination with gene silencing and X chromo-
some inactivation [22–24]. uH2A levels at Polycomb-repressed
promoters decrease in RING1A/B deﬁcient cells, followed by in-
creased expression of the normally repressed targets [22,25,26].
Further analysis of promoters at derepressed genes after knock
down of Ring1a/b and global loss of H2A ubiquitination in mouse
ES cells shows association of PolII with regions downstream of
the promoters, supporting a model where H2A ubiquitination hin-
ders transcription at the stage of elongation but not initiation [27].
The ﬁnding that ubiquitinated H2A may act as a restraint for
poised RNA PolII on gene promoters and a block for transcriptional
Fig. 1. Ubiquitination and deubiquitination of histones H2A and H2B regulate chromatin during transcription. (A) Schematic representation of the sequential events in
ubiquitination/deubiquitination of H2B in yeast. Rad6-Bre1 E2–E3 complex is recruited to activated genes by the Paf1 transcription elongation complex, which associates
with transcribing RNA PolII. H2B is ubiquitinated at lysine 123 by the Bre1 E3 ubiquitin ligase and the Set1 methyltransferase is subsequently recruited to the active
promoters where it tri-methylates H3K4. In order for transcriptional elongation to proceed, ubiquitin needs to be removed from H2B via the enzymatic activity of Ubp8,
which is part of the SAGA complex. (B) Schematic representation of the ubiquitination/deubiquitination of H2A in mammals. H2A is ubiquitinated by RNF20/40 E3 ubiquitin
ligase and blocks RNA polII before the elongation stage. For transcription elongation to proceed, ubiquitin needs to be removed from H2A by a deubiquitinating enzyme, such
as USP21. Whether the trans-regulation of trimethylation of H3K4 by H2B ubiquitination is conserved in mammalian cells is controversial, as described in the text.
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E3 ubiquitin ligase that is recruited by the repressive complex nu-
clear receptor co-repressor/histone deacetylase 1/3 to promoters of
chemokine genes of macrophages, monoubiquitinates H2A and
blocks RNA polII release at the elongation stage [28]. However, a
more recent study challenges the causative link between H2A
ubiquitination and blockage of RNA polII activity by showing that
Ring1B-regulated chromatin compaction and gene repression is
not dependent on a functional RING domain of the ligase and thus
is independent of histone H2A ubiquitination [29]. The functional
analysis of the DUBs that have been shown to regulate the levels
of ubiquitinated H2A like 2A-DUB, USP21 and USP22, favor a
repressive rather than an activating role for H2A ubiquitination
on transcription. 2A-DUB has been characterized as an androgen
receptor (AR) coactivator, as it deubiquitinates H2A at the pro-
moter of AR target genes, facilitates the dissociation of H1 and acti-
vates transcription [30]. Similarly, the deubiquitinating enzyme
USP22 is required with ataxin7-like 3 (ATXN7L3) and human
ortholog of enhancer of yellow 2 (ENY2) for the full transcriptional
activity of the AR [31]. In contrast to H2B ubiquitination that isrequired for H3K4 trimethylation in yeast, H2A ubiquitination
needs to be removed by deubiquitinating enzyme for H3K4 di
and tri-methylation to occur in mammalian cells [32]. USP21,
speciﬁcally, relieves ubH2A-dependent repression and facilitates
transcription initiation by allowing H3K4 trimethylation in regen-
erating mouse liver (Fig. 1B) [32].
An inverse cross-talk mechanism has been observed between
H3K27 methylation by methyltransferase human ortholog of
enhancer of zeste 2 and H2AK119 ubiquitination by Ring1B E3
ligase [26]. PRC2 functions as a histone methyltransferase that
trimethylates histone H3 on lysine 27 (H3K27me3). This mark acts
as a recruiting platform for PRC1, which catalyzes the ubiquitina-
tion of histone H2A on K119 [22,25,33] and is required for homeo-
box (Hox) gene silencing. Evidence for another level of cross talk
between histone H2A ubiquitination and histone acetylation arises
from the association of deubiquitinating enzyme 2A-DUB and
P/CAF [30]. Hyperacetylated nucleosomes enhance the deubiquiti-
nation of H2A by 2A-DUB. The deubiquitinating enzyme is re-
cruited to the activated promoter through its interaction with
the acetyltransferase P/CAF, a mechanism reminiscent of the
Table 1
Deubiquitinating enzymes implicated in chromatin regulation.
Enzyme Enzyme
family
Complex
association
Substrates Process
2A-DUB JAMM 2A DUB uH2A Regulation of transcription
USP3 USP None uH2A and uH2B DNA repair: Regulation of the cell cycle progression
USP7 USP PRC1 uH2A and uH2B, MEL18, BMI1 Regulation of gene expression, Protein stability
USP16 USP None H2A DNA repair, Regulation of the cell cycle progression.
USP21 USP None H2A Regulation of gene expression, Capable of removing NEDD8 from NEDD8 conjugates
USP22 USP SAGA uH2A, uH2B, TRF1 Regulation of gene expression; Cell proliferation; Protein stability
BRCC36 JAMM BRCA1-A K63 poly uH2A, uH2A.X DNA repair, Capable of removing K63 linked polyubiquitin
List of DUBs with histone H2A and H2B deubiquitination activity implicated in regulation of chromatin related processes. DUBs are listed by enzymatic family, the complexes
by which they are associated, their known substrates and processes they regulate.
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acetyltransferase general control non-derepressible 5 (Gcn5) for
the transcriptional activation of target genes. The interacting part-
ners 2A-DUB and P/CAF, are recruited to the promoter region, re-
move the uH2A repressive mark and facilitate the dissociation of
linker proteins, creating an open chromatin environment.
3. DUBs involved in chromatin regulation
Several DUBs have been identiﬁed so far to remove ubiquitin
moieties from chromatin templates in mammals, mainly deubiqui-
tinating histones H2A and H2B. Among these histone DUBs are:
2A-DUB/MYSM1, USP3, USP7, Ubp-M/USP16, USP21, USP22 and
BRCA1-containing complex (BRCC36) [30–32,34–38] (Table 1). All
of these enzymes exert higher deubiquitination (DUB) activity to-
ward ubiquitinated histone H2A (uH2A) compared to their activity
toward ubiquitinated histone H2B (uH2B) in vitro and in vivo. This
observation is in line with the fact that ubiquitination of H2A in
higher eukaryotes appears to be the predominant histone mark,
compared to the abundance of H2B ubiquitination [39,40]. How-
ever, all of the enzymes mentioned above are capable of H2A
and/or H2B deubiquitination, raising questions about the regula-
tion of DUB activity in time and space. There are several possible
mechanisms by which the speciﬁc activity of these enzymes might
be regulated, (1) integration into multisubunit complexes and
interaction with different partners, (2) different expression levels
during the cell cycle and different tissues.
3.1. Complex integration and regulation of the DUB activity by
interacting partners
Some DUBs work as a part of multisubunit complexes (i.e., 2A-
DUB, USP22, USP7). USP22 and 2A-DUB are enzymatically active
as part of the SAGA and 2A-DUB complexes, respectively
[30,31,41]. The importance of interacting partners for the regula-
tion of DUB activity is especially valid for USP22, where interactions
with its complex partners ENY2 and ATXN7L3 are required for en-
zyme function. The three proteins are part of a sub domain in the
complex known as the SAGA deubiquitination module [31,41,42].
More evidence about the mechanism of how the interacting part-
ners regulate the DUB activity came from the recently published
crystal structures of the yeast SAGA DUB module [43,44]. The
authors of these studies demonstrated that S1 gene upstream of
ySa1 and SAGA associated factor 11 (sgf11) and Sgf73 (yeast homo-
logs of ENY2 and ATXN7L3 and ATXN7)maintain the ‘‘active confor-
mation” of the enzyme. ATXN7 which is another bona ﬁde SAGA
component was also shown to anchor the DUB module to the com-
plex [31] and to further facilitate histone deubiquitination by pro-
viding interactions with nucleosomes [45]. Both the 2A-DUB and
SAGA complexes also harbor histone acetyltransferase (HAT) sub-
units, P/CAF and its homolog GCN5, respectively. How and whether
the presence of HATs in these complexes regulates their DUB activ-ity remains elusive. However, the in vitro activity of 2A-DUB is
signiﬁcantly higher toward uH2A when incorporated in acetylated
nucleosomes and in addition, the depletion of P/CAF leads to in-
creased levels of uH2A in vivo [30]. Experimental evidence address-
ing whether the USP22 activity is also impaired by the acetylation
level of the targeted nucleosomes is not yet available. It is worth
mentioning however, that ablation of GCN5 in mammalian cells
diminishes the DUB activity of the SAGA complex, at least towards
non-histone substrates [46]. Although, the exact mechanism by
which acetylation and the presence of P/CAF in the 2A-DUB com-
plex enhances the DUB activity is unclear. Besides the HAT domain,
both P/CAF and GCN5 also contain bromodomains, which recognize
acetylated lysines [47,48]. It is tempting to speculate that the brom-
odomains of these enzymes are involved in substrate recognition
and targeting of the DUB activity of the complexes towards ubiqui-
tinated lysines adjacent to acetylated residues.
Very recently the human polycomb repressive complex 1
(PRC1) was found to co-purify with two DUBs, USP7 and USP11
[34]. This ﬁnding was surprising since the PRC1 complex is mostly
known for its role in gene repression conferred by H2A monoubiq-
uitination. A deubiquitinating enzymewith uH2A speciﬁcity, called
Calipso, was also found in the Drosophila Polycomb complex. The
function of this DUB is important for Hox gene regulation in fruit
ﬂies [49]. Interestingly, the enzymatic activity of this DUB is also
regulated by ASX, which is a Calipso interacting partner within
the complex. From the USPs that co-purify with hPRC1 complex
however, only USP7 displays activity toward uH2A and uH2B
in vitro and overexpression of USP7 impacts uH2A levels in vivo.
USP11, in contrast, does not seem to alter H2A/H2B ubiquitination
levels either in vitro or in vivo [34].
BRCC36 provides another example ofmodulation of DUB activity
by its interacting partners. This enzyme functions as a part of the
breast–ovarian cancer-susceptibility 1-A (BRCA1-A) complex and
is mainly associated with deubiquitination of H2A/H2AX K63-spe-
ciﬁc polyubiquitination during DNA repair [38,50,51]. While the
activity of this enzyme in the nucleus appears to be regulated by
its interaction with coiled-coil domain-containing protein 98 with-
in the BRCA1-A complex, association with the cytosolic protein
(KIAA0157) activate the enzyme in the cytoplasm [38].
USP3 and USP16 are not known to be associated with any com-
plexes to date. Since these DUBs possess activity independent of
other interacting partners or complex integration [36,37], they
are different from the DUBs described above. Both USP3 and
USP16 are also associated with H2A deubiquitination following
DNA damage processing [35,52]. It is possible that the interaction
with some factors involved in DNA repair further facilitates their
speciﬁc activity.
3.2. Connections between cell cycle and regulation of USP function
Some USPs may also be regulated during the cell cycle. Both
USP16 and USP22, for example, have different cellular localizations
Fig. 2. Regulation of chromatin related DUBs during cell cycle. The activity of several H2A/H2B deubiquitinases are associated with speciﬁc stages of the cell cycle. USP22,
acting as a part of the SAGA complex, regulates the G1–S phase transition, perhaps by altering the expression level of different cell cycle related loci. It is possible that SAGA
also regulates the ubiquitination state of different transcriptional regulators. Other H2A DUBs such as USP21 and 2A-DUB contribute to the regulation of cell proliferation,
since USP21 function is required for hepatocyte cell cycle reentry during liver regeneration. Depletion of USP3 in cells leads to aberrant S-phase progression and accumulation
of double-strand breaks (DSBs) suggesting a function of this DUB in the DNA replication and repair. BRCC36 modulates the chromatin K63 linked polyubiquitination in
response of DNA damage. The DUB localize to DSBs and removes ubiquitin, antagonizing the RNF8-dependent ubiquitination at these foci. The regulation of USP16 appears to
be more complicated. This DUB is mostly cytoplasmic during interphase of the unperturbed cell cycle and localizes to chromosomes during mitosis. This transition is
regulated by phosphorylation and dephosphorylation throughout the cell cycle. USP16 is also engaged in the transcriptional reactivation after DNA repair. Perhaps the
enzyme gets phosphorylated in response of DNA damage and relocalizes to the nucleus where it alters the ubiquitination state on the affected chromatin loci. Regulation of
the DUBs activity by their postranslational modiﬁcation during the cell cycle might be a commonmechanism since USP22 was also found to be modiﬁed by acetylation and its
localization during the mitosis differ from the localization during the interphase. It remains to be determined whether and what kind of post-translational modiﬁcations
govern the activity of USP3, BRCC36 other chromatin associated DUBs.
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cytoplasm during interphase and associates with chromosomes
during mitosis [36]. USP22 on the other hand, is mostly nuclear
during interphase but does not localize to mitotic chromosomes
during mitosis [53]. UPS16 is phosphorylated at the onset of mito-
sis and dephosphorylated during the metaphase/anaphase transi-
tion. Thus, USP16 localization and activity may be controlled by
posttranslational modiﬁcations as well. USP22 and USP7 are also
posttranslationaly modiﬁed. USP22 is acetylated [54], and USP7
is phosphorylated [55]. Interestingly, the USP7 phosphorylation
sites are located close to protein–protein interaction domains
[55], suggesting that the activity and cellular localization of these
enzymes might also be controlled via changes in posttranslational
modiﬁcations.
Lastly, USP3 and USP22 have completely opposite tissue expres-
sion patterns. USP22 appears to be ubiquitously expressed in hu-
man tissues, whereas its expression in mouse is most abundant
in brain and greatly diminished in liver [56]. USP3 on the other
hand is almost absent in human brain and is relatively well ex-
pressed in liver [57]. The distinct expression pattern of these en-
zymes suggests that deubiquitination of H2A and H2B and other
chromatin substrates is targeted by diverse DUBs in different tis-
sues and during speciﬁc stages of the cell cycle. Redistribution of
these enzymes in different cellular compartments suggests addi-tional levels of control of their function (Fig. 2). The functional
meaning of this DUB diversity remains to be uncovered, but it
seems plausible that these enzymes and the complexes they form
are engaged in the regulation of different subset of substrates and/
or genomic loci. Clearly, more studies on interacting partners,
expression levels and posttranslational modiﬁcations are needed
to elucidate fully how these chromatin DUBs are regulated.4. Impact of DUBs activity on nuclear processes
The details of how H2A/H2B deubiquitination impacts gene
expression in mammalian cells remains largely unknown.
Although all of the above mentioned DUBs target uH2A and
uH2B for deubiquitination it seems that the different DUBs have
quite distinct impacts on cell cycle progression. Depletion of
USP22, for example, leads to increased cell population in the G1
phase, demonstrating that USP22 is necessary for proper cell cycle
progression. [41]. USP3 is required for proper S-phase progression,
as its depletion leads to a delay in S-phase, whereas knockdown of
USP16 results in defective mitosis [36,37]. The different roles of
these enzymes in cell cycle control suggest that: (1) these DUBs
control the deubiquitination of different chromatin loci altering
the expression levels of different subset of genes and (2) the DUB
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Indeed, Maertens and colleagues demonstrated that USP7 and
USP11 control the expression levels of p16IKN4a through regulation
of the ubiquitination level and protein turnover of PCR1 complex
components, rather than by modulating the uH2A/H2B levels at
this locus [34]. USP3 and BRCC36 are more clearly involved in
DNA repair [35], and BRCC36 is associated with removal of K63-
linked H2A polyubiquitination as well as K63-linked deubiquitina-
tion of other unspeciﬁed yet non-histone substrates during DNA
repair [50,51,58]. The activity of USP3 is crucial for H2A/H2B mono
deubiquitination and phosphorylated histone variant H2A.X
dephosphorylation during the repair process [35]. This observation
agrees with the fact that ubiquitination of chromatin surrounding
DNA lesions signals the DNA repair machinery [50,59]. Deubiquiti-
nation of these loci, then, will be needed to deactivate checkpoints
and for transcriptional reactivation after the repair process is com-
pleted [52]. It is also possible that active deubiquitination is asso-
ciated with nucleosomal eviction and exchange of H2A/H2B during
DNA repair. This possibility stems from the fact that USP3 deple-
tion leads to S-phase delay and accumulation of DNA breaks, which
might reﬂect aberrant nucleosomal exchange at the active sites
during DNA repair and replication. Indeed, a functional link be-
tween H2A deubiquitination and H1 phosphorylation followed by
its release from the chromatin has been reported [30]. The details
of how deubiquitination of histones and other chromatin tem-
plates regulate cell cycle progression and DNA repair remains to
be elucidated. It is highly anticipated that a substantial number
of non-histone proteins engaged in the DNA metabolism have yet
to be identiﬁed as substrates of the histone DUBs as well.5. Non-histone chromatin substrates of DUBs
A growing list of evidence suggests that the regulation of gene
expression occurs not only through ubiquitination and deubiqui-
tination of histones but also of other chromatin related sub-
strates. Recently, USP22, acting as a part of the mammalian
SAGA complex, was shown to regulate the ubiquitination levels
and protein stability of telomeric-repeat binding factor 1 (TRF1),
one of the main components of the telomere protective complex
called shelterin [46]. This ﬁnding was one of the ﬁrst to show that
a deubiquitinating enzyme, mostly known from its function on
histones, targets another chromatin associated protein. TRF1 is
ubiquitinated after its release from the telomeres [60] in human
cells and is further targeted for proteasomal degradation. It is
likely that USP22 ‘‘recycles” TRF1 by deubiquitination, making it
available for reincorporation into telomeres. Perhaps this function
is one of the reasons why USP22 is overexpressed in rapidly pro-
liferating cancer cells [61].
USP7 (which is capable of H2A and H2B deubiquitination) and
USP11 regulate the ubiquitination levels and turnover of chromatin
bound PRC1 complex components MEL18 and BMI, which in turn
impacts the transcriptional regulation of p16INK4a [34]. USP7 is also
known to regulate p53 function by altering its ubiquitination levels
[62], as well as the ubiquitination levels and the turnover of murine
double minute 2 gene (Mdm2) [63,64]. It is worth mentioning that
death-domain-associated protein (DAXX), which was recently
identiﬁed as a histone H3.3 chaperone [65,66], was also found as
a USP7 interacting protein [63,64]. It will be interesting to deter-
mine if USP7 also deubiquinates and modulates DAXX function,
impacting its ability to facilitate histone H3.3 incorporation at
telomeric regions. Another DUB, USP21, which is important for
uH2A deubiquitination and transcriptional activation during liver
regeneration [32] was recently shown to control the ubiquitination
levels of receptor-interacting protein 1, event important for the
proper functioning of the tumor necrosis factor alpha pathway [67].Besides K63-linked polyubiquitination of H2A, several non-his-
tone proteins are ubiquitinated when DNA damage occurs. The
polyubiquitin chains of these substrates are proposed to serve as
an anchor for DNA repair machinery, and their deubiquitination
is needed after the repair process is completed. What these sub-
strates might be, however, still need to be discovered. So far the
only DUB capable of processing K63-linked polyubiquitin chains
during the DNA repair is BRCC36. It remains to be seen if some
of the other chromatin associated DUBs exert K63 speciﬁcity to-
ward histone or non-histone substrates.6. Chromatin regulation by DUBs and cancer development
Although the role of DUBs involved in chromatin deubiquitina-
tion and transcriptional regulation has been extensively analyzed
in yeast, the precise role of these enzymes in mammalian cells
and their contribution to the tumorigenesis is still elusive.
Advances in the transcriptional proﬁling of tumor cells identiﬁed
an 11-gene signature that characterizes patients with poor progno-
sis and likely to suffer death after treatment [68]. This signature
has been described in multiple different cancer types, suggesting
the presence of a possibly conserved mechanism that drives
tumorigenesis that may reﬂect a cancer stem cell phenotype. Three
of the identiﬁed genes in the 11 gene signature, Bmi1, Ring1B and
USP22, are involved in regulation of histone ubiquitination or
deubiquitination. Bmi1 and Ring1B are subunits of the mammalian
PRC1 complex and the fact that Ring1B speciﬁcally represses
p16Ink4a [69] may explain how Ring1B overexpression is linked
to aggressive human tumors [68]. Although the simultaneous
activity of Ring1B E3 ligase and USP22 deubiquitinating enzyme
has not been addressed in different types of cancers, an alternative
model for cancer progression has been suggested involving the ﬁne
tuning of histone ubiquitination levels by Ring1B and USP22 [41].
USP22 knockdown produces an accumulation of cells in the G1
phase of the cell cycle and leads to a reduction in transcription of
several Myc and p53 regulated genes [41]. These results suggest
that USP22 positively regulates MYC-dependent transcription,
which may at least partially explain its oncogenic properties. Inter-
estingly, Zhang and colleagues [41] found that the depletion of
USP22 does not affect the activation of p53 upregulated modulator
of apoptosis, a p53 target gene, indicating that USP22 has a gene-
speciﬁc role in regulating the p53 transcriptional network. Zhao
et al. [31] on the other hand, reported a critical role for USP22 in
AR-mediated transcactivation, in both Drosophila and human cells.
According to this study, the oncogenic potential of USP22 overex-
pression may arise from the misregulation of AR, as uncontrolled
AR activity contributes to the development of prostate cancer [70].
Usp7 has been characterized as the deubiquitinating enzyme for
H2B that is involved in epigenetic silencing of homeotic genes in
ﬂies [71]. The human ortholog of USP7 can deubiquitinate addi-
tional targets besides histone H2A, including Mdm2 and p53, and
the deubiquitination of these targets ultimately determines func-
tional p53 levels [62]. Mdm2, rather than p53, appears to be the
preferred substrate of USP7, resulting in Mdm2 stabilization as
USP7 antagonizes autoubiquitination of Mdm2 and consequently
induces the degradation of p53 [72,73]. USP7 has also been shown
to deubiquitinate forkhead box-containing transcription factor 4,
provoking its nuclear export and hence its inactivation [74]. The
tumor suppressor phosphatase and tensin homolog deleted on
chromosome ten is also deubiquitinated by USP7, resulting in its
nuclear export and inactivation. In the same study, USP7 overex-
pression in prostate cancer was associated with tumor metastasis
[63]. A recent work showed that USP7 and USP11 DUBs play a role
in the regulation of inhibitor for cyclin-dependent kinase 4/alter-
native reading frame (INK4a/ARF) locus. INK4a/ARF locus encodes
2022 B.S. Atanassov et al. / FEBS Letters 585 (2011) 2016–2023two powerful inhibitors of cell cycle progression, p16Ink4a and
p19Arf, a negative regulator of p53 [75], and is one of the critical
targets of polycomb group (PcG)-mediated repression in mammals.
Mice lacking particular PcG genes display defects in stem and pro-
genitor cell renewal that is attributable to de-repression of Ink4a/
Arf locus [69,76]. Usp7 and Usp11 are associated with chromatin
and bind to several PRC1 components in high-molecular-weight
complexes. Importantly, knockdown of either USP results in de-
repression of INK4a and displacement of PRC1 proteins from the
locus. Knockdown of USP7 or USP11 causes increased turnover of
chromatin-bound MEL18 and BMI1, whereas over-expression of
the USPs reduces the levels of mono- and poly-ubiquitination of
these proteins [7].
BRCA1-associated protein 1 (BAP1) is the largest member of the
UCH subfamily of DUBs and it has been found to interact with sev-
eral proteins like BRCA1 and the transcriptional cofactor host cell
factor (HCF-1) [77,78]. Deubiquitinating activity of BAP1 seems
to be important in cancer pathogenesis. Missense mutations that
abolish the deubiquitinating activity of BAP1 (A95D and G178V)
have been identiﬁed in cancer cell lines [79,80]. Although the
molecular mechanism of BAP1 tumorigenicity is attributed to the
regulation of BRCA1 E3 ligase activity or the turnover of HCF-1, a
recent study shows that calypso the BAP1 homolog in Drosophila,
exists in a complex with the PcG protein Asx and affects HOX genes
regulation by regulating the levels of H2A ubiquitination [49]. The
DUB activity of BAP1 in mammalian cells was also implicated in
the transcriptional regulation [81]. BAP1 is recruited to its target
genes via interaction with YY1 to modulates transcriptional initia-
tion. It will be interesting to see if BAP1 regulates the ubiquitina-
tion levels of histone H2A at these loci or whether its DUB
activity is targeted toward other transcriptional regulators at these
sites.
7. Concluding remarks
It became clear during the recent years that ubiquitination and
deubiquitination of chromatin templates regulates major cellular
processes such as gene expression, DNA repair and DNA replica-
tion. Ubiquitination of chromatin substrates impacts these pro-
cesses at several levels, directly by altering protein stability and
protein localization (monoubiquitination K48 or K63 polyubiquiti-
nation), or indirectly by regulating other posttranslational chroma-
tin modiﬁcations such as phosphorylation or methylation. Most of
the identiﬁed DUBs share the same major chromatin substrates,
ubiquitinated histones H2A/H2B, and yet their activities appear
to have distinct impact on downstream processes. This fact raises
questions about the temporal and spatial regulation of these en-
zymes activities and highlights the importance of studies elucidat-
ing their interacting partners and expression patterns. Discovering
other, non-histone chromatin related substrates for these enzymes
will shed further light on how cell cycle or tissue speciﬁc gene
expression programs are regulated through both ubiquitination
and deubiquitination.
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